Immunotherapy for Inhalant Allergy
Introduction
Introduction
- Allergic rhinitis (AR) and allergic asthma (AA) are caused by an immunoglobulin E (IgE) mediated inflammatory response to proteins (or glycoproteins) carried by inhaled organic particles such as pollen, animal dander, mold spores, and/or mite/insect debris.
- Inhalant allergies can be treated by immunotherapy, pharmaceuticals, or by reducing environmental exposure to the allergen.
- Inhalant allergen immunotherapy (AIT) is administered to millions of patients for AR and AA and is most commonly delivered as subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT).
- Variability in the initiation and delivery of safe and effective immunotherapy provides opportunities for evidence-based recommendations to improve patient care.
Treatment
...atment
...e 1. Abbreviations and Definitions of Common Ter...
...e 2. Summary of Guideline Key Action St...
...ssessme...
...cy for Allergen ImmunotherapyClinicians should of...
...ho should not get Allergen ImmunotherapyClinician...
...ay not get Allergen ImmunotherapyClinicians may...
...smentClinicians should evaluate the patient o...
Education
...garding SLIT versus SCITClinicians shou...
...Education regarding Preventive Qualit...
...eatment...
...Pre-/Co-Seasonal TherapyClinicians w...
.... Selecting Clinically Relevant AllergensC...
...eating Polysensitized Patients with...
...ctions and Allergen Immunotherapy...
10. Anaphylaxis Identification and ManagementT...
...Retesting During Allergen ImmunotherapyClinici...
...ion for Allergen ImmunotherapyFor p...
...Comparison of SCIT and SLIT Modalities o...
.... World Allergy Organization Subcutaneous I...
...igure 1. Pre-/Co-Seasonal SLIT Time CourseTime c...
...phylaxis Diagnostic Criteria Reproduced fr...
...ntiating Between Vasovagal and AnaphylaxisHav...
...re 3. Management of AnaphylaxisReproduc...
...Flowchart Showing Key Action Statements and...